Pediatric Dermatology Journal Articles

 
 
  • Tralokinumab for Atopic Dermatitis: A Promising New Therapy Multiple trials of tralokinumab, an interleukin-13 inhibitor, indicate that it is a promising treatment option for patients with moderate-to-severe atopic dermatitis.
  • Asthma, SARS-CoV-2 and COVID-19 What have we learned about the interaction between asthma and COVID-19? Might asthma medications have an impact on outcomes?
  • Association of COVID-19 With Skin Diseases and Biologics Might underlying skin diseases or exposure to biologics used to treat these conditions increase susceptibility to or mortality from COVID-19?
  • Immune-mediated Diseases and Risk of IBD Are individuals with other immune-mediated diseases at greater risk of developing ulcerative colitis or Crohn's disease?
  • Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis Review current evidence for the use of crisaborole 2% ointment, a topical phosphodiesterase-4 inhibitor, for the treatment of atopic dermatitis.
  • Nicotinamide: Safety & Differences From Niacin Nicotinamide, a form of vitamin B3, is an oral treatment option for actinic keratosis, squamous and basal cell carcinomas, and bullous pemphigoid. How does it relate to niacin--and how is it used?
  • Hormonal Contraceptives and Dermatology Hormonal contraceptives can be beneficial for some dermatologic conditions, while detrimental to others. Review their use in a variety of skin disorders in this paper.
  • Intersection of PCOS and the Gut Microbiome A new review examines the possible association between the gut microbiome and PCOS. Is there a connection?
  • Pediatric Psoriasis Comorbidities This case presentation highlights the many comorbidities that can manifest in children with psoriasis, including juvenile psoriatic arthritis, uveitis, and metabolic disorders.
  • Efficacy of Treatments for PCOS Management in Adolescents Learn more about the safety and efficacy of various treatment options for PCOS in the adolescent population.
  • Selective JAK1 Inhibitors for Treatment of Atopic Dermatitis Review the role of the JAK/STAT pathway in atopic dermatitis, and the pharmacology of the JAK1 inhibitors upadacitinib and abrocitinib, which provide novel oral therapeutic options for this disease.
  • Dermatologic Applications and Safety of JAK Inhibitors Janus kinase inhibitors offer promise for a number of immunologically driven conditions. What are their potential clinical applications in dermatology?
  • Advances in Allergen Immunotherapy for Asthma What have we learned about the benefits of allergen immunotherapy as a therapeutic option for asthma?
  • Expanding Treatment Options for Rosacea A new study reports on the beneficial effects of topical minocycline on papulopustular rosacea.
  • Efficacy of Benralizumab for Severe Eosinophilic Asthma A new study evaluates the efficacy of benralizumab for severe eosinophilic asthma in a real-life setting.
  • Insulin Sensitizers for Overweight Women With PCOS What benefits might overweight women with PCOS gain from treatment with insulin sensitizers?
  • The Use of Radiofrequency in Aesthetic Surgery Learn more about the different types of radiofrequency technology and how they can apply to the field of aesthetic surgery.
  • Intestinal Microbiota and Child Health A better understanding of the role of the intestinal microbiota in the development of chronic health issues in children could have important implications for prevention and treatment.
  • Young People's Perceptions of Acne and Acne Treatments A better understanding of the views of young people with acne could have important implications for self-management and treatment adherence.
  • Baricitinib in Moderate-to-Severe Atopic Dermatitis Baricitinib may provide another treatment option for patients with atopic dermatitis who did not adequately respond to corticosteroid therapy.